Mouse device with a built-in printer
A mouse device for use as an input device of a computer is provided that includes a housing in which recording paper is loadable, and a printer unit provided within the housing for printing on the recording paper print information received from the computer.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120029211 | Catalytic Wittig and Mitsunobu Reactions A catalytic Wittig method utilizing a phosphine including the steps of providing a phosphine oxide precatalyst and reducing the phosphine oxide precatalyst to produce the phosphine; forming a phosphonium ylide precursor from the phosphine and a reactant; generating a ph... | 02/02/2012 |
| 20120029162 | CARBON NANOTUBES COMPRISING HYDROXY GROUPS, METHOD FOR THE PRODUCTION THEREOF AND POLYURETHANE POLYMERS COMPRISING SAID CARBON NANOTUBES The invention relates to carbon nanotubes comprising hydroxy groups, wherein the surface thereof comprises hydroxy alkyl ester groups covalently bound thereon, chosen from the group according to the general formula (1) and/or the general formula (2), wherein (CNT) stand... | 02/02/2012 |
| 20110237798 | DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID A method is provided for the preparation of an aromatic carboxylic acid aryl ester or an N-aryl aromatic carboxamide. The method comprises contacting an O,O-diaryl thiocarbonate or an O-aryl-N-aryl thiocarbamate with a reactant that regioselectively reacts with sulfur, ... | 09/29/2011 |
| 20110207939 | FACTOR VIIA INHIBITOR The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rhe... | 08/25/2011 |
| 20110201598 | Pharmaceutical Compositions Comprising RET Inhibitors and Methods for the Treatment of Cancer A class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer is described. The compounds' ability to inhibit RET kinase is quantified, i.e., their respective RET IC50 and EC50 values are described. One such compound, known as ... | 08/18/2011 |
| 20110195362 | RESIST UNDERLAYER FILM COMPOSITION, PROCESS FOR FORMING RESIST UNDERLAYER FILM, PATTERNING PROCESS AND FULLERENE DERIVATIVE There is disclosed a resist underlayer film composition of a multilayer resist film used in lithography including (A) a fullerene derivative having a carboxyl group protected by a thermally labile group and (B) an organic solvent. There can be a resist underlayer film c... | 08/11/2011 |
| 20110178200 | REACTIVE MESOGENIC COMPOUNDS AND MIXTURES The invention relates to new reactive mesogenic compounds (RM), polymerisable liquid crystal (LC) mixtures and polymers comprising them, and the use of the compounds, mixtures and polymers in optical, electrooptical, electronic, semiconducting or luminescent components ... | 07/21/2011 |
| 20110166372 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE CARBOXYLIC ACID ESTER COMPOUND, ASYMMETRIC COPPER COMPLEX, AND OPTICALLY ACTIVE SALICYLIDENEAMINOALCOHOL COMPOUND A process for producing an optically active cyclopropanecarboxylic acid ester compound represented by the formula (4): (wherein R5, R6 and * each represents the same meaning as defined b... | 07/07/2011 |
| 20110132439 | FULLERENE COMPOUNDS FOR SOLAR CELLS AND PHOTODETECTORS Amorphous fullerene derivatives and their use in organic electronic devices that include the fullerene derivative as the electron acceptor component in the device's active layer.... | 06/09/2011 |
| 20110105544 | CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER The invention provides novel compounds of formula (I), wherein: R1 is a radical derived from one of the known ring systems; R2 is a phenyl radical optionally substituted; Xn represents a birradical selected from the group consisting of: ... | 05/05/2011 |
| 20110089380 | Fullerene Multi-Adduct Compositions One aspect of the invention relates to compositions comprising one or more fullerene derivatives that comprise one or more covalent addends. In certain embodiments, the fullerene derivatives are selected from the group consisting of methanofullerene derivatives, Prato a... | 04/21/2011 |
| 20110092724 | METHOD OF PRODUCING A PRODUCT BASED ON VEGETABLE OIL A composition, which is suitable for the production of stilbene compounds, can be separated from tall oil. It contains esters of pinosylvin or pinosylvin derivatives and it is concentrated in relation to these. Preferably, the composition contains esters of pinosylvin m... | 04/21/2011 |
| 20110065047 | PHOTORESIST COMPOSITION The present invention provides a photoresist composition comprising a resin, an acid generator and a compound represented by the formula (I):
| |
| 20110015423 | Functionalized Carbon Nanostructures Which are Soluble in Hydrocarbons and Method for Preparation Carbon nanomaterials functionalized on their surface with ester or amide functionality are made using a technique involving multiple space apart in time or dropwise additions of reactants to the carbon nanomaterials, and are soluble in hydrocarbon liquids.... | 01/20/2011 |
| 20100331218 | PHOTOACID GENERATORS FOR THE SYNTHESIS OF OLIGO-DNA IN A POLYMER MATRIX Compounds represented by the following structural formulas can be used as photoacid generators: Such compounds are useful, for example, in fabricating arrays of polymers.... | 12/30/2010 |
| 20100292128 | Organic Compounds Described are spiroalkyl- and -alkenylketones and esters thereof, a method for their production and fragrance compositions comprising them.... | 11/18/2010 |
| 20100286022 | EDIBLE AND BIOCOMPATIBLE METAL-ORGANIC FRAMEWORKS The disclosure relates generally to materials that comprise organic frameworks. The disclosure also relates to materials that are useful to store and separate biological agents that are environmentally friendly and biocompatible.... | 11/11/2010 |
| 20100276633 | ENHANCEMENT OF THE STRUCTURE AND PROPERTIES OF CARBON NANOTUBE FIBRES AND FILMS A method of increasing the density of carbon nanotube fibres or films containing carbon nanotubes to at least 50% w/w, said method including the steps of exposing the fibre or film to suitable density enhancing agent, or to electromagnetic radiation, or by applying heat... | 11/04/2010 |
| 20100274039 | CATALYST COMPOSITION INCLUDING ZIRCONIUM COMPOUNDS FOR ESTERFICATION REACTION AND METHOD FOR PREPARING ESTER COMPOUNDS The present invention relates to an esterification catalyst composition that includes a zirconium compound and a method for producing an ester compound, which includes the steps of esterifying alcohol and carboxylic acid compounds by using the same, and it may be applie... | 10/28/2010 |
| 20100256367 | Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives The present invention relates to a use of a specific alpha-arylmethoxyacrylate derivative, or its pharmacologically acceptable salt or solvate for preventing and treating metabolic bone diseases.... | 10/07/2010 |
| 20100234610 | METHOD FOR PRODUCING OPTICALLY ACTIVE ESTER AND METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID Disclosed is a method for producing an optically active ester by highly selectively esterifying one enantiomer of a racemic carboxylic acid, while producing an optically active carboxylic acid which is the other enantiomer. An optically active ester is produced while pr... | 09/16/2010 |
| 20100221656 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS A photosensitive compound has two or more structural units, in a molecule, represented by the following general formula (1): wherein R1 to R8 are selected from the group consisting of a ... | 09/02/2010 |
| 20100168459 | SYNTHESIS OF PHENOLIC ESTERS OF HYDROXYMETHYL PHENOLS The present invention provides a process for the production of a compound of formula (I) or a salt thereof, wherein R is hydrogen, a straight, branched or cyclic C1-C6 alkyl group or an aryl group which may optionally be substituted. This process c... | 07/01/2010 |
| 20100137250 | NAPHTHYLACETIC ACIDS The invention is concerned with the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and ... | 06/03/2010 |
| 20100093955 | PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME The present invention relates to a photoreactive polymer that comprises a multi-cyclic compound in a main chain, and a polymerization method thereof. Since the photoreactive polymer according to the present invention comprises a multi-cyclic compound having a high glass... | 04/15/2010 |
| 20100040548 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of antimicrobials and antimicrobial-related compounds, which are capable of crossing biological barriers with high penetration efficiency. The HPPs are ca... | 02/18/2010 |
| 20100029904 | Carrier for Separation, Method for Separation of Compound, and Method for Synthesis of Peptide Using the Carrier A carrier for use for separation purpose and a method for separation of a compound enable a chemical reaction to be performed in a liquid phase, a compound of interest to be separated from the liquid phase after the completion of the reaction readily, the separated comp... | 02/04/2010 |
| 20100009991 | POLYCYCLIC ACID COMPOUNDS USEFUL AS CRTH2 ANTAGONISTS AND ANTIALLERGIC AGENTS The present invention relates to a novel compound or a salt thereof, which is useful as a CRTH2 antagonist, especially as a medicament for disorder that participates eosinophil, for example, allergic disorder such as asthma, allergic rhinitis, allergic dermatitis, conju... | 01/14/2010 |
| 20090299076 | Axially asymmetric ester compound and production method thereof To provide an axially asymmetric optically active biaryl ester compound that can easily produced without the step of optical resolution which was almost indispensable in conventional methods. There is provided a method for producing an axially asymmetric ester compound,... | 12/03/2009 |
| 20090203773 | Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X The present invention relates to compounds of the formula (I); wherein R1 is H, CH3 or OCH3; R3=H, OH, CH3, OCH3, O-glucose or benzoyloxy; R4=H; R5=H or OH; R6=H or OCH 08/13/2009 | |
| 20090197198 | PHOTOSENSITIVE MOLECULAR COMPOUND AND PHOTORESIST COMPOSITION INCLUDING THE SAME Disclosed are a photosensitive compound containing oxime group which is directly decomposed by exposure to light, which is a molecular resist whose size is smaller than conventional polymer for photoresist, and a photoresist composition including the same. The photosens... | 08/06/2009 |
| 20090161516 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES The invention discloses novel dicyanostilbene derivatives bound to a methacrylic moiety that can serve as an active chromophore in a 3-dimensional optical memory, processes for its synthesis and its intermediates.... | 06/25/2009 |
| 20090149533 | NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT The invention provides novel omega-3 ester-based oil solutions of fenofibrate. These solutions are substantially free of any food effect, effective in small volumes, and readily bioavailable. Notably, because the solutions of the invention contain an omega-3 ester-based... | 06/11/2009 |
| 20090069577 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same In one embodiment of the present invention, a silicon-based cross-coupling reagent is disclosed which is a highly stable tetraorganosilicon compound allowing for a cross-coupling reaction under mild reaction conditions without using fluoride ions, transition metal promo... | 03/12/2009 |
| 20090062149 | PHOTOACID GENERATORS FOR THE SYNTHESIS OF OLIGO-DNA IN A POLYMER MATRIX Compounds represented by the following structural formulas can be used as photoacid generators: Such compounds are useful, for example, in fabricating arrays of polymers.... | 03/05/2009 |
| 20090050844 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION A polymerizable liquid crystal composition of the present invention includes a compound including a repeated unit represented by a general formula (I) (wherein R1, R2, R3, and... | 02/26/2009 |
| 20090054435 | Phenoxyalkanoic Acid Compound The present invention provides a compound represented by the formula: wherein each symbol is as defined in the specification. Since the compound of the present invention has supe... | 02/26/2009 |
| 20080300261 | Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease Compounds of formula I are useful in treatment of diseases associated with the deposition of β-amyloid in the brain.... | 12/04/2008 |
| 20080293695 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance Drug substances comprising a pharmaceutically acceptable organic acid addition salt 6f amine containing pharmaceutically active compounds useful for the treatment of a therapeutic ailment administration and exhibiting prophylactic properties when employed in non-therape... | 11/27/2008 |
| 20080293764 | LPA RECEPTOR ANTAGONIST A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence is useful in... | 11/27/2008 |